Home
About
Pricing
Log In
Back
NFM
Asset Logo

New Frontier Minerals Limited

πŸ‡¦πŸ‡Ί ASX

⛏️ MINING

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-12.56%
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

7
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

New Frontier Minerals Ltd. engages in the business of mineral exploration and examination of new resource opportunities which focuses on copper, cobalt, and rare earth elements projects in Australia and Zambia. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-14. Its projects include the Harts Range Project and the NWQ Copper Project. The Harts Range Project comprises two granted tenements and an application license for a total of 135 square kilometers (km2), approximately 140 kilometers (km) north-east of Alice Springs, with mining infrastructure and access to a skilled labor pool. The Harts Range Project is situated northwest of the Entia Dome and lies within the Harts Range Group. The NWQ Copper Project comprises five mineral leases, covering a total area of 977 km2. The NWQ Copper Project is located approximately 150 km north of Mt Isa in Queensland, and hosts several historic / operating copper mines, including Lady Annie, Mt Oxide and Capricorn Copper. Its additional project, Mkushi Project, is located within the Mwembeshi Shear Zone (MSZ).

πŸ“ˆ Performance

Price History

+700.00%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.02

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in NFM

7

πŸ“Š Total Capital Earnings

$8K

πŸ”ƒ Average investment frequency

27 weeks

πŸ’΅ Average investment amount

$1,312

⏰ Last time a customer invested in NFM

14 hours
NFM investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

25%

100k - 150k

50%

50k - 100k

Less than 50k

25%
πŸ‘Ά Age of investors

18 - 25

14%

26 - 34

43%

35 - 90

43%
πŸ™‹ Legal gender of investors

Female

57%

Male

43%

Pearlers who invest in NFM also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

9.37%

πŸ“Š Share price

$111.56 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

πŸ’Έ FINANCIALS

🧱 MATERIALS

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 51,346 full-time employees. Its segments include Retail Banking Services, Business Banking, Institutional Banking and Markets, New Zealand, and Corporate Center and Other. Retail Banking Services provides banking products and services to personal and private bank customers, helping them to manage their everyday banking needs, buy a home or invest in the future. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial services solutions. The company also provides equities trading and margin lending services through the CommSec business. Institutional Banking and Markets offers a full range of domestic and global financing and banking services to institutional and government clients. New Zealand includes the banking and funds management businesses operating in New Zealand under the ASB brand.

πŸ™Œ Performance (5Yr p.a)

31.51%

πŸ“Š Share price

$170.38 AUD

πŸ“ˆ HIGH PRICE GROWTH

🏦 BANKING

Wesfarmers Ltd. engages in the provision of fresh food, groceries, general merchandise, liquor, fuel, and financial services. The company is headquartered in Perth, Western Australia and currently employs 118,000 full-time employees. Its Kmart segment is a retailer of apparel and general merchandise, including toys, leisure, entertainment, home and consumables. Its Energy and Fertilizers (WesCEF) segment is a manufacturer and marketer of chemicals for industry, mining and mineral processing. Its Officeworks segment is a retailer and supplier of office products and solutions for households and small-to-medium-sized businesses. Its Industrial and Safety segment is a supplier and distributor of maintenance, repair and operating products. Its Wesfarmers Health (Health) segment is a wholesaler and retailer of pharmaceutical goods, health, wellness and beauty products. Its Catch segment is an online retailer offering branded products on a first-party basis and a third-party online marketplace. Its Other segments include OneDigital, Forest products, and Property.

πŸ™Œ Performance (5Yr p.a)

22.15%

πŸ“Š Share price

$91.55 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ›οΈ CONSUMER

PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. The firm utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The firm's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.

πŸ™Œ Performance (5Yr p.a)

123.56%

πŸ“Š Share price

$1.14 AUD

🧬 BIOTECHNOLOGY

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

23.02%

πŸ“Š Share price

$67.97 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

2.02%

πŸ“Š Share price

$89.20 AUD

πŸ’° HIGH DIVIDEND

πŸ“Š Share price

$0.03 AUD
Compare
Add to watchlist